Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas

British Journal of Cancer

Volumn 99, Issue 2, 2008, Pages 357-363

  Tan, H K ^a,b   Saulnier, P ^a   Auperin, A ^a   Lacroix, L ^a   Casiraghi, O ^a   Janot, F ^a   Fouret, P ^a,c   Temam, S ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

HNSCC; Hypermethylation; Margins; Prognostic; QMSP; Recurrence

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CCNA1 PROTEIN, HUMAN; CYCLIN A;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CCNAI GENE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DCC GENE; DISEASE FREE SURVIVAL; FEMALE; FIBROBLAST GROWTH FACTOR RECEPTOR 2 GENE; FOLLOW UP; HEAD CANCER; HUMAN; HUMAN TISSUE; HYPOPHARYNX; LARYNX; MALE; MOUTH CAVITY; MULTIVARIATE ANALYSIS; NECK CANCER; ONCOGENE; OROPHARYNX; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROSPECTIVE STUDY; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; SURGICAL ANATOMY; CANCER STAGING; DNA METHYLATION; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN A; DNA METHYLATION; FEMALE; GENES, DCC; GENES, P16; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROMOTER REGIONS (GENETICS); PROPORTIONAL HAZARDS MODELS;

EID: 48249130820     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604478     Document Type: Article

References (48)

1. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM, Sidransky D (1993) The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53: 4477-4480
2. Braakhuis BJ, Leemans CR, Brakenhoff RH (2005) Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. Semin Cancer Biol 15: 113-120
3. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D (1995) Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 429-435
4. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56: 2488-2492
5. Carvalho AL, Chuang A, Jiang WW, Lee J, Begum S, Poeta L, Zhao M, Jeronimo C, Henrique R, Nayak CS, Park HL, Brait MR, Liu C, Zhou S, Koch W, Fazio VM, Ratovitski E, Trink B, Westra W, Sidransky D, Moon CS, Califano JA (2006) Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res 66: 9401-9407
6. Davidson TM, Nahum AM, Astarita RW (1981) Microscopic controlled excisions for epidermoid carcinoma of the head and neck. Otolaryngol Head Neck Surg 89: 244-251
7. Dominguez G, Carballido J, Silva J, Silva JM, Garcia JM, Menendez J, Provencio M, Espana P, Bonilla F (2002) p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients. Clin Cancer Res 8: 980-985
8. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, Laird PW (2001) Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61: 3410-3418
9. Esteller M, Fraga MF, Paz MF, Campo E, Colomer D, Novo FJ, Calasanz MJ, Galm O, Guo M, Benitez J, Herman JG (2002) Cancer epigenetics and methylation. Science 297: 1807-1808; discussion 1807-1808
10. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG (1999) Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59: 67-70
11. Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR (2007) The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132: 127-138
12. Goessl C, Krause H, Muller M, Heicappell R, Schrader M, Sachsinger J, Miller K (2000) Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res 60: 5941-5945
13. Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH, Koch WM, Sidransky D, Califano JA (2004) Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 130: 39-44
14. Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, Sidransky D (2003) Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res 9: 1370-1375
15. Hockel M, Dornhofer N (2005) The hydra phenomenon of cancer: why tumors recur locally after microscopically complete resection. Cancer Res 65: 2997-3002
16. Jesse RH, Sugarbaker EV (1976) Squamous cell carcinoma of the oropharynx: why we fail. Am J Surg 132: 435-438
17. Ji P, Agrawal S, Diederichs S, Baumer N, Becker A, Cauvet T, Kowski S, Beger C, Welte K, Berdel WE, Serve H, Muller-Tidow C (2005) Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells. Oncogene 24: 2739-2744
18. Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin J, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, Demeester TR, Eads C, Laird PW, Ilson DH, Kelsen DP, Harpole D, Moore MB, Danenberg KD, Danenberg PV, Meltzer SJ (2000) Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 92: 1805-1811
19. Kim WY, Sharpless NE (2006) The regulation of INK4/ARF in cancer and aging. Cell 127: 265-275
20. Koscielny S, Dahse R, Ernst G, von Eggeling F (2007) The prognostic relevance of p16 inactivation in head and neck cancer. ORL J Otorhinolaryngol Relat Spec 69: 30-36
21. Kowalski LP, Magrin J, Waksman G, Santo GF, Lopes ME, de Paula RP, Pereira RN, Torloni H (1993) Supraomohyoid neck dissection in the treatment of head and neck tumors. Survival results in 212 cases. Arch Otolaryngol Head Neck Surg 119: 958-963
22. Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266
23. Laird PW, Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3Spec No: 1487-1495
24. Lo YM, Wong IH, Zhang J, Tein MS, Ng MH, Hjelm NM (1999) Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res 59: 3899-3903
25. Martone T, Gillio-Tos A, De Marco L, Fiano V, Maule M, Cavalot A, Garzaro M, Merletti F, Cortesina G (2007) Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res 13: 5089-5094
26. Mehlen P, Fearon ER (2004) Role of the dependence receptor DCC in colorectal cancer pathogenesis. J Clin Oncol 22: 3420-3428
27. Momparler RL (2003) Cancer epigenetics. Oncogene 22: 6479-6483
28. Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ (2002) Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Laryngoscope 112: 2129-2140
29. Papadimitrakopoulou VA, Oh Y, El-Naggar A, Izzo J, Clayman G, Mao L (1998) Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. Clin Cancer Res 4: 539-544
30. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
31. Proebstle TM, Huber R, Sterry W(1996) Detection of early micrometastases in subcutaneous fat of primary malignant melanoma patients by identification of tyrosinase-mRNA. Eur J Cancer 32A: 1664-1667
32. Puri SK, Si L, Fan CY, Hanna E (2005) Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 26: 12-17
33. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349: 247- 257
34. Righini CA, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, Favrot MC (2007) Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 13: 1179-1185
35. Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG, Sidransky D (2000) Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60: 892-895
36. Sardi I, Franchi A, Ferriero G, Frittelli A, Bruschini L, Montali E, Gallo O (2000) Prediction of recurrence by microsatellite analysis in head and neck cancer. Genes Chromosomes Cancer 29: 201-206
37. Shaw RJ, Hall GL, Lowe D, Bowers NL, Liloglou T, Field JK, Woolgar JA, Risk JM (2007a) CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology. Oral Oncol 43: 878-886
38. Shaw RJ, Hall GL, Woolgar JA, Lowe D, Rogers SN, Field JK, Liloglou T, Risk JM (2007b) Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 45: 617-622
39. Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, Field JK, Risk JM (2006) Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing. Br J Cancer 94: 561-568
40. Sidransky D (2002) Emerging molecular markers of cancer. Nat Rev Cancer 2: 210-219
41. Silva JM, Dominguez G, Garcia JM, Gonzalez R, Villanueva MJ, Navarro F, Provencio M, San Martin S, Espana P, Bonilla F (1999) Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res 59: 3251-3256
42. Silva JM, Garcia JM, Dominguez G, Silva J, Miralles C, Cantos B, Coca S, Provencio M, Espana P, Bonilla F (2002) Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann Surg Oncol 9: 71-76
43. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6: 963-968
44. Temam S, Casiraghi O, Lahaye JB, Bosq J, Zhou X, Julieron M, Mamelle G, Lee JJ, Mao L, Luboinski B, Benard J, Janot F (2004) Tetranucleotide microsatellite instability in surgical margins for prediction of local recurrence of head and neck squamous cell carcinoma. Clin Cancer Res 10: 4022-4028
45. Theodorescu D, Frierson Jr HF, Sikes RA (1999) Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. J Urol 161: 1442-1448
46. van Houten VM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, van den Brekel MW, Snow GB, Brakenhoff RH (2004) Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study. Clin Cancer Res 10: 3614-3620
47. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793
48. Zou HZ, Yu BM, Wang ZW, Sun JY, Cang H, Gao F, Li DH, Zhao R, Feng GG, Yi J (2002) Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 8: 188-191